Peptest is the latest non-invasive test for reflux diagnostics worldwide. It is a precise, painless and relatively cheap saliva test, which can provide a reliable proof of the presence of reflux disease.
Pepsin, which is needed for splitting proteins, occurs naturally in the stomach. However, if pepsin also occurs outside the stomach, the individual suffers from reflux. That is why we take samples of saliva and test the presence of pepsin.
Considering the concentration of pepsin in the saliva sample we can determine how severe the reflux is. At the same time the prospects of ensuing treatment are assessed. The test can be carried out again during the treatment.
Patients of all ages who suffer from long-term difficulties such as:
980 CZK – the test is not covered by public health insurance
Oběrové pracoviště COVID-19 - Genetika Plzeň
Odběrové pracoviště - hraniční přechod Dolní Dvořiště
Notification for patients - COVID-19
In the context of the testing of and the search for people infected with one of types of coronaviruses, we notify our patients that the clinic is operating without restrictions, none of our personnel are showing symptoms of respiratory disease and none of them have travelled to areas with identified increased occurrence of this virus.
Using this questionnaire, we actively search for potentially infected individuals amongst our patients.
NEXTCLINICS Continues to Dynamically Grow
NEXTCLINICS, a provider of premium health care services and a leader in smart health, has over the last three months enjoyed dynamic growth and evolution. The company has gone through significant changes, all leading to building a stable brand that represents quality health care with high value-added services including interactive communication between the patient and the health care facility.
New company name
Continuing dynamic development of NL-Holding brings another important change. The Czech subsidiary of NL-Holding, comprising of the three constituent parts, which including Next Lab (and then Next Clinic and Next Life), was renamed. The name of NL-Holding a.s. was replaced by NEXTCLINICS Czech a.s., more info here.
Ke dni 30.11.2017 došlo k přesunutí laboratoře alergologie a klinické imunologie NL – LAB IMUNO ALERGO s.r.o. Příbram do Prahy
From 31th December 2016 to 31th December 2017 is providing laboratory services in Genetics Lab Kralupy nad Vltavou stopped
Odběrové místo Praha - Poliklinika Palmovka v pátek 18. listopadu 2016 uzavřeno.
Dne 31.10.2016 došlo k převodu 100% majetkové účasti v příbramské laboratoři IMUNO-ALERGO s.r.o.
Nové odběrové místo v Českých Budějovicích
Rádi bychom vás informovali o otevření nového odběrového místa v Českých Budějovicích. Dne 8. 7. 2016 jsme pro vás otevřeli odběrové místo na ulici Milady Horákové 1437, 370 05 České Budějovice.
Dne 8.7.2016 došlo k převodu 100% majetkové účasti v klatovské laboratoři BioLab spol. s r.o.
Nový přístroj v naší laboratoři
Češi si nehlídají cholesterol. Často ani nevědí, jakou mají hladinu
Nová zdravotnická platforma CareKit má za cíl zefektivnit léčbu
Spotřebitel 2016: Čím dál víc investuje do svého zdraví
NEXTLAB provides fast and accurate laboratory diagnostics on biological material for private GPs, outpatient specialists, hospitals, patients without a health insurance policy, and those who request laboratory services beyond standard testing.
NEXTLAB builds upon 20 years of experience with its own labs and sample collection centres, offering a wide range of lab tests based on the latest diagnostic methods, devices and technologies. Tests that are not carried out in our labs are forwarded to partner labs in compliance with a strict pre-analytical procedure. NEXTLAB labs meet the criteria of Audit II NASKL and ČIA. NEXTLAB has contracts with all major health insurance companies and is flexible enough to provide additional services related to lab diagnostics.